Bancap Hc

   
Google
 
Web NewDrugInformation.com

Bancap Hc


Drug - Bancap Hc
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Hydrocodone Bitartrate
Multiple ingredients are in alphabetical order.

Strength - 500MG;5MG
The potency of the active ingredient(s), Acetaminophen; Hydrocodone Bitartrate. May repeat for multiple part products.

Applicant - FOREST PHARMS
The firm name holding legal responsibility for Bancap Hc. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 087961
The FDA assigned number to Bancap Hc. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bancap Hc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 17, 1983
The date Bancap Hc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bancap Hc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Bancap Hc is in. Format is RX, OTC, DISCN.

Applicant Full Name - Forest Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Bancap Hc.

Bancap Hc